Gennova launches cut-price pegfilgrastim in India
This article was originally published in Scrip
Executive Summary
Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals of India, has launched its indigenously developed pegfilgrastim on the domestic market, as Pegex.